The role of hormones, cytokines and heat shock proteins during age-related muscle loss

Clinical Nutrition

Volumn 26, Issue 5, 2007, Pages 524-534

  Lee, Claire E ^a   McArdle, Anne ^a   Griffiths, Richard D ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Androgen; Estrogen; Heat shock factor; Immune function; Muscle; Sarcopenia; Testosterone

Indexed keywords

ANDROGEN; CYTOKINE; ESTROGEN; HEAT SHOCK PROTEIN; HORMONE; INTERLEUKIN 6; SEX HORMONE; SOMATOMEDIN C; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

AGING; CRITICALLY ILL PATIENT; CYTOKINE RELEASE; DIETARY INTAKE; ELDERLY CARE; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; INFLAMMATION; MENOPAUSAL SYNDROME; MUSCLE ATROPHY; MUSCLE FUNCTION; MUSCLE INJURY; MUSCLE MASS; MUSCLE REGENERATION; MUSCLE STRENGTH; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PROTECTION; PUBLIC HEALTH PROBLEM; REVIEW; SEX DIFFERENCE; SKELETAL MUSCLE; SKELETAL MUSCLE SATELLITE CELL; STEROID BLOOD LEVEL;

AGING; CYTOKINES; ESTROGENS; FEMALE; HEAT-SHOCK PROTEINS; HORMONES; HUMANS; MALE; MUSCULAR ATROPHY; SEX FACTORS; TESTOSTERONE;

EID: 35449003229     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2007.05.005     Document Type: Review

References (153)

1. Rosenberg I.H. Sarcopenia: origins and clinical relevance. J Nutr 127 Suppl. 5 (1997) 990S
2. Baumgartner R.N., Koehler K.M., Gallagher D., Romero L., Heymsfield S.B., Ross R.R., et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147 8 (1998) 755
3. Melton 3rd L.J., Khosla S., Crowson C.S., O'Connor M.K., O'Fallon W.M., and Riggs B.L. Epidemiology of sarcopenia. J Am Geriatr Soc 48 6 (2000) 625
4. Poehlman E.T., Toth M.J., and Fonong T. Exercise, substrate utilization and energy requirements in the elderly. Int J Obesity Relat Metab Disord 19 Suppl. 4 (1995) S93
5. Griffiths R.D. Muscle mass, survival, and the elderly ICU patient. Nutrition 12 6 (1996) 456
6. Baumgartner R.N., Waters D.L., Gallagher D., Morley J.E., and Garry P.J. Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev 107 2 (1999) 123
7. Abbasi A., Duthie Jr. E.H., Sheldahl L., Wilson C., Sasse E., Rudman I., et al. Association of dehydroepiandrosterone sulfate, body composition, and physical fitness in independent community-dwelling older men and women. J Am Geriatr Soc 46 3 (1998) 263
8. Roubenoff R., and Hughes V.A. Sarcopenia: current concepts. J Gerontol A Biol Sci Med Sci 55 12 (2000) M716
9. Dirks A.J., Hofer T., Marzetti E., Pahor M., and Leeuwenburgh C. Mitochondrial DNA mutations, energy metabolism and apoptosis in aging muscle. Ageing Res Rev 5 2 (2006) 179
10. Gallagher D., Visser M., De Meersman R.E., Sepulveda D., Baumgartner R.N., Pierson R.N., et al. Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol 83 1 (1997) 229
11. Luff A.R. Age-associated changes in the innervation of muscle fibers and changes in the mechanical properties of motor units. Ann N Y Acad Sci 854 (1998) 92
12. Porter M.M., Vandervoort A.A., and Lexell J. Aging of human muscle: structure, function and adaptability. Scand J Med Sci Sports 5 3 (1995) 129
13. Skelton D.A., Greig C.A., Davies J.M., and Young A. Strength, power and related functional ability of healthy people aged 65-89 years. Age Ageing 23 5 (1994) 371
14. Brooks S.V., and Faulkner J.A. Contractile properties of skeletal muscles from young, adult and aged mice. J Physiol 404 (1988) 71
15. Brooks S.V., and Faulkner J.A. Contraction-induced injury: recovery of skeletal muscles in young and old mice. Am J Physiol 258 3Pt 1 (1990) C436
16. Zerba E., Komorowski T.E., and Faulkner J.A. Free radical injury to skeletal muscles of young, adult, and old mice. Am J Physiol 258 3Pt 1 (1990) C429
17. Lexell J., Taylor C.C., and Sjostrom M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J Neurol Sci 84 2,3 (1988) 275
18. Lexell J. Human aging, muscle mass, and fiber type composition. J Gerontol A Biol Sci Med Sci 50 Spec No (1995) 11
19. Larsson L., and Karlsson J. Isometric and dynamic endurance as a function of age and skeletal muscle characteristics. Acta Physiol Scand 104 2 (1978) 129
20. Faulkner J.A., Brooks S.V., and Zerba E. Skeletal muscle weakness and fatigue in old age: underlying mechanisms. Annu Rev Gerontol Geriatr 10 (1990) 147
21. Thompson L.V. Effects of age and training on skeletal muscle physiology and performance. Phys Ther 74 1 (1994) 71
22. Kirkendall D.T., and Garrett Jr. W.E. The effects of aging and training on skeletal muscle. Am J Sports Med 26 4 (1998) 598
23. Tidball J.G. Inflammatory cell response to acute muscle injury. Med Sci Sports Exerc 27 7 (1995) 1022
24. Merly F., Lescaudron L., Rouaud T., Crossin F., and Gardahaut M.F. Macrophages enhance muscle satellite cell proliferation and delay their differentiation. Muscle Nerve 22 6 (1999) 724
25. Close G.L., Kayani A., Vasilaki A., and McArdle A. Skeletal muscle damage with exercise and aging. Sports Med 35 5 (2005) 413
26. Mauro A. Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9 (1961) 493
27. Charge S.B., and Rudnicki M.A. Cellular and molecular regulation of muscle regeneration. Physiol Rev 84 1 (2004) 209
28. Collins C.A., Olsen I., Zammit P.S., Heslop L., Petrie A., Partridge T.A., et al. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122 2 (2005) 289
29. Gibson M.C., and Schultz E. The distribution of satellite cells and their relationship to specific fiber types in soleus and extensor digitorum longus muscles. Anat Rec 2 3 (1982) 329
30. Wokke J.H., Van den Oord C.J., Leppink G.J., and Jennekens F.G. Perisynaptic satellite cells in human external intercostal muscle: a quantitative and qualitative study. Anat Rec 223 2 (1989) 174
31. Schmalbruch H., and Hellhammer U. The number of nuclei in adult rat muscles with special reference to satellite cells. Anat Rec 189 2 (1977) 169
32. Schultz E., Jaryszak D.L., and Valliere C.R. Response of satellite cells to focal skeletal muscle injury. Muscle Nerve 8 3 (1985) 217
33. Schultz E., and McCormick K.M. Skeletal muscle satellite cells. Rev Physiol Biochem Pharmacol 123 (1994) 213
34. Hawke T.J., and Garry D.J. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 91 2 (2001) 534
35. LaBarge M.A., and Blau H.M. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 111 4 (2002) 589
36. Bittner R.E., Schofer C., Weipoltshammer K., Ivanova S., Streubel B., Hauser E., et al. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol (Berlin) 199 5 (1999) 391
37. Morgan J.E., and Partridge T.A. Muscle satellite cells. Int J Biochem Cell Biol 35 8 (2003) 1151
38. Grounds M.D. Reasons for the degeneration of ageing skeletal muscle: a central role for IGF-1 signalling. Biogerontol 3 1,2 (2002) 19
39. Renault V., Thornell L.E., Butler-Browne G., and Mouly V. Human skeletal muscle satellite cells: aging, oxidative stress and the mitotic clock. Exp Gerontol 37 10,11 (2002) 1229
40. Conboy I.M., and Rando T.A. Aging, stem cells and tissue regeneration: lessons from muscle. Cell Cycle 4 3 (2005) 407
41. McArdle A., Dillmann W.H., Mestril R., Faulkner J.A., and Jackson M.J. Overexpression of HSP70 in mouse skeletal muscle protects against muscle damage and age-related muscle dysfunction. Faseb J 18 2 (2004) 355
42. Shi X., and Garry D.J. Muscle stem cells in development, regeneration, and disease. Genes Dev 20 13 (2006) 1692
43. Ehrhardt J., and Morgan J. Regenerative capacity of skeletal muscle. Curr Opin Neurol 18 5 (2005) 548
44. Gibson M.C., and Schultz E. Age-related differences in absolute numbers of skeletal muscle satellite cells. Muscle Nerve 6 8 (1983) 574
45. Renault V., Piron-Hamelin G., Forestier C., DiDonna S., Decary S., Hentati F., et al. Skeletal muscle regeneration and the mitotic clock. Exp Gerontol 35 6,7 (2000) 711
46. Carlson B.M., and Faulkner J.A. Muscle transplantation between young and old rats: age of host determines recovery. Am J Physiol 256 6Pt 1 (1989) C1262
47. Conboy I.M., Conboy M.J., Wagers A.J., Girma E.R., Weissman I.L., and Rando T.A. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433 7027 (2005) 760
48. McArdle A., Vasilaki A., and Jackson M. Exercise and skeletal muscle ageing: cellular and molecular mechanisms. Ageing Res Rev 1 1 (2002) 79
49. Houry W.A. Chaperone-assisted protein folding in the cell cytoplasm. Curr Protein Pept Sci 2 3 (2001) 227
50. Locke M, Noble E. Excersice and stress response:the role of stress proteins. Boca Raton (FL); 2002.
51. McArdle A., Pattwell D., Vasilaki A., Griffiths R.D., and Jackson M.J. Contractile activity-induced oxidative stress: cellular origin and adaptive responses. Am J Physiol Cell Physiol 280 3 (2001) C621
52. Vasilaki A., Jackson M.J., and McArdle A. Attenuated HSP70 response in skeletal muscle of aged rats following contractile activity. Muscle Nerve 25 6 (2002) 902
53. Vasilaki A., McArdle F., Iwanejko L.M., and McArdle A. Adaptive responses of mouse skeletal muscle to contractile activity: the effect of age. Mech Ageing Dev 127 11 (2006) 830
54. Fargnoli J., Kunisada T., Fornace Jr. A.J., Schneider E.L., and Holbrook N.J. Decreased expression of heat shock protein 70 mRNA and protein after heat treatment in cells of aged rats. Proc Natl Acad Sci USA 87 2 (1990) 846
55. Wu B., Gu M.J., Heydari A.R., and Richardson A. The effect of age on the synthesis of two heat shock proteins in the hsp70 family. J Gerontol 48 2 (1993) B50
56. Locke M., and Tanguay R.M. Diminished heat shock response in the aged myocardium. Cell Stress Chaperones 1 4 (1996) 251
57. McArdle A., Broome C.S., Kayani A.C., Tully M.D., Close G.L., Vasilaki A., et al. HSF expression in skeletal muscle during myogenesis: implications for failed regeneration in old mice. Exp Gerontol 41 5 (2006) 497
58. Naito H., Powers S.K., Demirel H.A., and Aoki J. Exercise training increases heat shock protein in skeletal muscles of old rats. Med Sci Sports Exerc 33 5 (2001) 729
59. Roubenoff R. Catabolism of aging: is it an inflammatory process?. Curr Opin Clin Nutr Metab Care 6 3 (2003) 295
60. Visser M., Pahor M., Taaffe D.R., Goodpaster B.H., Simonsick E.M., Newman A.B., et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the health ABC study. J Gerontol A Biol Sci Med Sci 57 5 (2002) M326
61. Ferrucci L., Penninx B.W., Volpato S., Harris T.B., Bandeen-Roche K., Balfour J., et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 50 12 (2002) 1947
62. Volpato S., Guralnik J.M., Ferrucci L., Balfour J., Chaves P., Fried L.P., et al. Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation 103 7 (2001) 947
63. Pedersen B.K., Steensberg A., Fischer C., Keller C., Ostrowski K., and Schjerling P. Exercise and cytokines with particular focus on muscle-derived IL-6. Exerc Immunol Rev 7 (2001) 18
64. Febbraio M.A., and Pedersen B.K. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. Faseb J 16 11 (2002) 1335
65. Yende S., Waterer G.W., Tolley E.A., Newman A.B., Bauer D.C., Taaffe D.R., et al. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax 61 1 (2006) 10
66. Bautmans I., Njemini R., Lambert M., Demanet C., and Mets T. Circulating acute phase mediators and skeletal muscle performance in hospitalized geriatric patients. J Gerontol A Biol Sci Med Sci 60 3 (2005) 361
67. Leng S.X., Cappola A.R., Andersen R.E., Blackman M.R., Koenig K., Blair M., et al. Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res 16 2 (2004) 153
68. Tsujinaka T., Ebisui C., Fujita J., Kishibuchi M., Morimoto T., Ogawa A., et al. Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse. Biochem Biophys Res Commun 207 1 (1995) 168
69. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Hopper K., Lotsikas A., Lin H.M., et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85 3 (2000) 1151
70. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 15 (2000) 1767
71. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 12 (2000) 836
72. Pedersen B.K., Steensberg A., and Schjerling P. Muscle-derived interleukin-6: possible biological effects. J Physiol 536 Pt 2 (2001) 329
73. Guttridge D.C., Mayo M.W., Madrid L.V., Wang C.Y., and Baldwin Jr. A.S. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289 5488 (2000) 2363
74. Kawamura I., Morishita R., Tomita N., Lacey E., Aketa M., Tsujimoto S., et al. Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model. Gene Ther 6 1 (1999) 91
75. Reid M.B., and Li Y.P. Tumor necrosis factor-alpha and muscle wasting: a cellular perspective. Respir Res 2 5 (2001) 269
76. von Haehling S., Jankowska E.A., and Anker S.D. Tumour necrosis factor-alpha and the failing heart-pathophysiology and therapeutic implications. Basic Res Cardiol 99 1 (2004) 18
77. Phillips T., and Leeuwenburgh C. Muscle fiber specific apoptosis and TNF-alpha signaling in sarcopenia are attenuated by life-long calorie restriction. Faseb J 19 6 (2005) 668
78. Pedersen M., Bruunsgaard H., Weis N., Hendel H.W., Andreassen B.U., Eldrup E., et al. Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mech Ageing Dev 124 4 (2003) 495
79. Dupont-Versteegden E.E. Apoptosis in muscle atrophy: relevance to sarcopenia. Exp Gerontol 40 6 (2005) 473
80. Leeuwenburgh C. Role of apoptosis in sarcopenia. J Gerontol A Biol Sci Med Sci 58 11 (2003) 999
81. Adams G.R., and McCue S.A. Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. J Appl Physiol 84 5 (1998) 1716
82. Barton-Davis E.R., Shoturma D.I., Musaro A., Rosenthal N., and Sweeney H.L. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA 95 26 (1998) 15603
83. Chakravarthy M.V., Davis B.S., and Booth F.W. IGF-I restores satellite cell proliferative potential in immobilized old skeletal muscle. J Appl Physiol 89 4 (2000) 1365
84. Musaro A., McCullagh K., Paul A., Houghton L., Dobrowolny G., Molinaro M., et al. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 27 2 (2001) 195
85. Bakay M., Zhao P., Chen J., and Hoffman E.P. A web-accessible complete transcriptome of normal human and DMD muscle. Neuromuscul Disord 12 Suppl. 1 (2002) S125
86. Krishan K., and Dhoot G.K. Changes in some troponin and insulin-like growth factor messenger ribonucleic acids in regenerating and denervated skeletal muscles. J Muscle Res Cell Motil 17 5 (1996) 513
87. Bark T.H., McNurlan M.A., Lang C.H., and Garlick P.J. Increased protein synthesis after acute IGF-I or insulin infusion is localized to muscle in mice. Am J Physiol 275 1Pt 1 (1998) E118
88. Barton-Davis E.R., Shoturma D.I., and Sweeney H.L. Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle. Acta Physiol Scand 167 4 (1999) 301
89. Musaro A., McCullagh K.J., Naya F.J., Olson E.N., and Rosenthal N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 400 6744 (1999) 581
90. Lawlor M.A., and Rotwein P. Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21. Mol Cell Biol 20 23 (2000) 8983
91. Juul A., Bang P., Hertel N.T., Main K., Dalgaard P., Jorgensen K., et al. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 78 3 (1994) 744
92. Barton E.R., Morris L., Musaro A., Rosenthal N., and Sweeney H.L. Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol 157 1 (2002) 137
93. Butterfield G.E., Thompson J., Rennie M.J., Marcus R., Hintz R.L., and Hoffman A.R. Effect of rhGH and rhIGF-I treatment on protein utilization in elderly women. Am J Physiol 272 1Pt 1 (1997) E94
94. Barrett-Connor E. Estrogen and estrogen-progestogen replacement: therapy and cardiovascular diseases. Am J Med 95 5A (1993) 40S
95. Davison S.L., Bell R., Donath S., Montalto J.G., and Davis S.R. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 90 7 (2005) 3847
96. Ashcroft G.S., and Ashworth J.J. Potential role of estrogens in wound healing. Am J Clin Dermatol 4 11 (2003) 737
97. Tsitouras P.D. Effects of age on testicular function. Endocrinol Metab Clin North Am 16 4 (1987) 1045
98. Lamberts S.W., van den Beld A.W., and van der Lely A.J. The endocrinology of aging. Science 278 5337 (1997) 419
99. Snyder P.J. Effects of age on testicular function and consequences of testosterone treatment. J Clin Endocrinol Metab 86 6 (2001) 2369
100. Matsumoto A.M. Fundamental aspects of hypogonadism in the aging male. Rev Urol 5 Suppl. 1 (2003) S3
101. Gray A., Feldman H.A., McKinlay J.B., and Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts male aging study. J Clin Endocrinol Metab 73 5 (1991) 1016
102. Kaufman J.M., and Vermeulen A. Declining gonadal function in elderly men. Baillieres Clin Endocrinol Metab 11 2 (1997) 289
103. de Ronde W., van der Schouw Y.T., Muller M., Grobbee D.E., Gooren L.J., Pols H.A., et al. Associations of sex-hormone-binding globulin (SHBG) with non-SHBG-bound levels of testosterone and estradiol in independently living men. J Clin Endocrinol Metab 90 1 (2005) 157
104. Iannuzzi-Sucich M., Prestwood K.M., and Kenny A.M. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci 57 12 (2002) M772
105. Harris T. Muscle mass and strength: relation to function in population studies. J Nutr 127 Suppl. 5 (1997) 1004S
106. Douchi T., Yamamoto S., Nakamura S., Ijuin T., Oki T., Maruta K., et al. The effect of menopause on regional and total body lean mass. Maturitas 29 3 (1998) 247
107. Poehlman E.T., and Tchernof A. Traversing the menopause: changes in energy expenditure and body composition. Coron Artery Dis 9 12 (1998) 799
108. Aloia J.F., McGowan D.M., Vaswani A.N., Ross P., and Cohn S.H. Relationship of menopause to skeletal and muscle mass. Am J Clin Nutr 53 6 (1991) 1378
109. Aloia J.F., Vaswani A., Russo L., Sheehan M., and Flaster E. The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass. Am J Obstet Gynecol 172 3 (1995) 896
110. Poehlman E.T., Toth M.J., and Gardner A.W. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med 123 9 (1995) 673
111. Calmels P., Vico L., Alexandre C., and Minaire P. Cross-sectional study of muscle strength and bone mineral density in a population of 106 women between the ages of 44 and 87 years: relationship with age and menopause. Eur J Appl Physiol Occup Physiol 70 2 (1995) 180
112. Sipila S., Taaffe D.R., Cheng S., Puolakka J., Toivanen J., and Suominen H. Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. Clin Sci (London) 101 2 (2001) 147
113. Gower B.A., and Nyman L. Associations among oral estrogen use, free testosterone concentration, and lean body mass among postmenopausal women. J Clin Endocrinol Metab 85 12 (2000) 4476
114. Taaffe D.R., Luz Villa M., Delay R., and Marcus R. Maximal muscle strength of elderly women is not influenced by oestrogen status. Age Ageing 24 4 (1995) 329
115. Tanko L.B., Movsesyan L., Svendsen O.L., and Christiansen C. The effect of hormone replacement therapy on appendicular lean tissue mass in early postmenopausal women. Menopause 9 2 (2002) 117
116. Kenny A.M., Dawson L., Kleppinger A., Iannuzzi-Sucich M., and Judge J.O. Prevalence of sarcopenia and predictors of skeletal muscle mass in nonobese women who are long-term users of estrogen-replacement therapy. J Gerontol A Biol Sci Med Sci 58 5 (2003) M436
117. Phillips S.K., Rook K.M., Siddle N.C., Bruce S.A., and Woledge R.C. Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clin Sci (London) 84 1 (1993) 95
118. Cauley J.A., Petrini A.M., LaPorte R.E., Sandler R.B., Bayles C.M., Robertson R.J., et al. The decline of grip strength in the menopause: relationship to physical activity, estrogen use and anthropometric factors. J Chronic Dis 40 2 (1987) 15
119. Brown M., Birge S.J., and Kohrt W.M. Hormone replacement therapy does not augment gains in muscle strength or fat-free mass in response to weight-bearing exercise. J Gerontol A Biol Sci Med Sci 52 3 (1997) B166
120. Kramer P.R., Kramer S.F., and Guan G. 17 beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages. Arthritis Rheum 50 6 (2004) 1967
121. Girasole G., Giuliani N., Modena A.B., Passeri G., and Pedrazzoni M. Oestrogens prevent the increase of human serum soluble interleukin-6 receptor induced by ovariectomy in vivo and decrease its release in human osteoblastic cells in vitro. Clin Endocrinol (Oxford) 51 6 (1999) 801
122. De Benedetti F., Alonzi T., Moretta A., Lazzaro D., Costa P., Poli V., et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest 99 4 (1997) 643
123. Lelbach A., Scharf J.G., and Ramadori G. Regulation of insulin-like growth factor-I and of insulin-like growth factor binding protein-1, -3 and -4 in cocultures of rat hepatocytes and Kupffer cells by interleukin-6. J Hepatol 35 5 (2001) 558
124. Sesmilo G., Miller K.K., Hayden D., and Klibanski A. Inflammatory cardiovascular risk markers in women with hypopituitarism. J Clin Endocrinol Metab 86 12 (2001) 5774
125. Cappola A.R., Xue Q.L., Ferrucci L., Guralnik J.M., Volpato S., and Fried L.P. Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab 88 5 (2003) 2019
126. Roubenoff R., Parise H., Payette H.A., Abad L.W., D'Agostino R., Jacques P.F., et al. Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham heart study. Am J Med 115 6 (2003) 429
127. Payette H., Roubenoff R., Jacques P.F., Dinarello C.A., Wilson P.W., Abad L.W., et al. Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: the Framingham heart study. J Am Geriatr Soc 51 9 (2003) 1237
128. Joseph C., Kenny A.M., Taxel P., Lorenzo J.A., Duque G., and Kuchel G.A. Role of endocrine-immune dysregulation in osteoporosis, sarcopenia, frailty and fracture risk. Mol Aspects Med 26 3 (2005) 181
129. Ershler W.B., and Keller E.T. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 51 (2000) 245
130. An J., Ribeiro R.C., Webb P., Gustafsson J.A., Kushner P.J., Baxter J.D., et al. Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators. Proc Natl Acad Sci USA 96 26 (1999) 15161
131. Paroo Z., and Dipchand E.S. Noble EGEstrogen attenuates postexercise HSP70 expression in skeletal muscle. Am J Physiol Cell Physiol 282 2 (2002) C245
132. Voss M.R., Stallone J.N., Li M., Cornelussen R.N., Knuefermann P., and Knowlton A.A. Gender differences in the expression of heat shock proteins: the effect of estrogen. Am J Physiol Heart Circ Physiol 285 2 (2003) H687
133. Tenover J.L. Testosterone and the aging male. J Androl 18 2 (1997) 103
134. Tenover J.L. Experience with testosterone replacement in the elderly. Mayo Clin Proc 75 Suppl. (2000) S77
135. Laughlin G.A., Barrett-Connor E., Kritz-Silverstein D., and von Muhlen D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo study. J Clin Endocrinol Metab 85 2 (2000) 645
136. Perry III H.M., Miller D.K., Patrick P., and Morley J.E. Testosterone and leptin in older African-American men: relationship to age, strength, function, and season. Metabolism 49 8 (2000) 1085
137. Szulc P., Duboeuf F., Marchand F., and Delmas P.D. Hormonal and lifestyle determinants of appendicular skeletal muscle mass in men: the MINOS study. Am J Clin Nutr 80 2 (2004) 496
138. Bhasin S., and Tenover J.S. Age-associated sarcopenia-issues in the use of testosterone as an anabolic agent in older men. J Clin Endocrinol Metab 82 6 (1997) 1659
139. Morley J.E., Perry III H.M., Kaiser F.E., Kraenzle D., Jensen J., Houston K., et al. Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc 41 2 (1993) 149
140. Urban R.J., Bodenburg Y.H., Gilkison C., Foxworth J., Coggan A.R., Wolfe R.R., et al. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol 269 5Pt 1 (1995) E820
141. Davis S.R., McCloud P., Strauss B.J., and Burger H. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 21 3 (1995) 227
142. Ferrando A.A., Sheffield-Moore M., Yeckel C.W., Gilkison C., Jiang J., Achacosa A., et al. Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab 282 3 (2002) E601
143. Ferrucci L., Bandinelli S., Benvenuti E., Di Iorio A., Macchi C., Harris T.B., et al. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc 48 12 (2000) 1618
144. Maggio M., Basaria S., Ceda G.P., Ble A., Ling S.M., Bandinelli S., et al. The relationship between testosterone and molecular markers of inflammation in older men. J Endocrinol Invest 28 Suppl. 11 Proceedings (2005) 116
145. Sinha-Hikim I., Cornford M., Gaytan H., Lee M.L., and Bhasin S. Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community-dwelling older men. J Clin Endocrinol Metab 91 8 (2006) 3024
146. Chen Y., Zajac J.D., and MacLean H.E. Androgen regulation of satellite cell function. J Endocrinol 186 1 (2005) 21
147. Sinha-Hikim I., Roth S.M., Lee M.I., and Bhasin S. Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men. Am J Physiol Endocrinol Metab 285 1 (2003) E197
148. Benjamin C.L., Jenster G., and Piedrahita J.A. Use of artificial androgen receptor coactivators to alter myoblast proliferation. J Steroid Biochem Mol Biol 91 3 (2004) 111
149. Lewis M.I., Horvitz G.D., Clemmons D.R., and Fournier M. Role of IGF-I and IGF-binding proteins within diaphragm muscle in modulating the effects of nandrolone. Am J Physiol Endocrinol Metab 282 2 (2002) E483
150. Kamanga-Sollo E., Pampusch M.S., Xi G., White M.E., Hathaway M.R., and Dayton W.R. IGF-I mRNA levels in bovine satellite cell cultures: effects of fusion and anabolic steroid treatment. J Cell Physiol 201 2 (2004) 181
151. Yen S.S., Morales A.J., and Khorram O. Replacement of DHEA in aging men and women. Potential remedial effects. Ann N Y Acad Sci 774 (1995) 128
152. Morales A.J., Haubrich R.H., Hwang J.Y., Asakura H., and Yen S.S. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol (Oxford) 49 4 (1998) 421
153. Anker S.D., Clark A.L., Kemp M., Salsbury C., Teixeira M.M., Hellewell P.G., et al. Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting. J Am Coll Cardiol 30 4 (1997) 997